| Code | Description | Claims | Beneficiaries | Total Paid |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
15,751 |
14,775 |
$4.71M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
19,324 |
18,675 |
$928K |
| 41899 |
Unlisted procedure, dentoalveolar structures |
373 |
339 |
$546K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
3,122 |
2,902 |
$364K |
| 42820 |
Tonsillectomy and adenoidectomy; younger than age 12 |
92 |
89 |
$337K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
4,867 |
4,658 |
$285K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
4,871 |
4,662 |
$285K |
| 80053 |
Comprehensive metabolic panel |
29,305 |
25,868 |
$234K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
31,605 |
27,414 |
$211K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,677 |
2,568 |
$144K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
2,793 |
2,726 |
$139K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
2,674 |
2,603 |
$115K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
172 |
151 |
$109K |
| 87800 |
|
1,632 |
1,566 |
$108K |
| 84443 |
Thyroid stimulating hormone (TSH) |
9,543 |
9,247 |
$89K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
1,191 |
1,185 |
$81K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,238 |
1,195 |
$66K |
| 86780 |
|
2,800 |
2,587 |
$66K |
| 86850 |
|
2,276 |
2,173 |
$55K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
537 |
318 |
$54K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
6,762 |
6,210 |
$44K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,336 |
1,145 |
$43K |
| 71045 |
Radiologic examination, chest; single view |
3,266 |
3,043 |
$40K |
| 81001 |
|
14,710 |
13,419 |
$39K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
561 |
307 |
$37K |
| 80061 |
Lipid panel |
8,772 |
8,626 |
$36K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,736 |
1,672 |
$34K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
4,822 |
2,769 |
$32K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
3,105 |
2,817 |
$31K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
837 |
820 |
$30K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
416 |
413 |
$29K |
| 84481 |
|
2,035 |
2,002 |
$27K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
4,676 |
4,624 |
$27K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
2,021 |
1,934 |
$25K |
| 83655 |
|
872 |
865 |
$25K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,124 |
1,076 |
$23K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
2,489 |
1,620 |
$22K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
467 |
340 |
$22K |
| 88142 |
|
1,273 |
1,198 |
$21K |
| 84439 |
|
3,642 |
3,565 |
$19K |
| 87070 |
|
2,200 |
2,085 |
$18K |
| 71046 |
Radiologic examination, chest; 2 views |
630 |
613 |
$17K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
397 |
381 |
$16K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,139 |
946 |
$16K |
| 84702 |
|
987 |
777 |
$16K |
| 36415 |
Collection of venous blood by venipuncture |
16,048 |
13,461 |
$15K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
1,362 |
1,361 |
$15K |
| 84703 |
|
2,360 |
2,177 |
$15K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
5,522 |
5,412 |
$13K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
555 |
538 |
$13K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
269 |
250 |
$12K |
| 86003 |
|
68 |
58 |
$12K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
13 |
13 |
$12K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
1,362 |
1,361 |
$12K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,773 |
1,326 |
$12K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
490 |
345 |
$11K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
92 |
90 |
$11K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
356 |
351 |
$10K |
| 87486 |
|
169 |
150 |
$9K |
| 87581 |
|
170 |
151 |
$9K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
2,009 |
1,729 |
$9K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
211 |
152 |
$8K |
| 87150 |
|
104 |
102 |
$8K |
| 83880 |
|
3,270 |
2,997 |
$7K |
| 82728 |
|
1,514 |
1,460 |
$7K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
747 |
738 |
$7K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
130 |
126 |
$6K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,025 |
694 |
$6K |
| 83690 |
|
2,817 |
2,579 |
$5K |
| 84484 |
|
3,159 |
2,660 |
$5K |
| 81025 |
|
822 |
795 |
$5K |
| 85027 |
|
2,792 |
2,651 |
$5K |
| 83970 |
|
1,276 |
1,244 |
$5K |
| 87340 |
|
433 |
419 |
$4K |
| 86803 |
|
600 |
590 |
$4K |
| 82043 |
|
2,142 |
2,122 |
$4K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
893 |
840 |
$4K |
| J0134 |
Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg |
455 |
429 |
$4K |
| 86762 |
|
143 |
138 |
$3K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
264 |
260 |
$3K |
| 71250 |
|
104 |
104 |
$3K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
63 |
63 |
$3K |
| 83735 |
|
3,639 |
3,224 |
$3K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,844 |
2,553 |
$3K |
| 84144 |
|
51 |
40 |
$3K |
| 85379 |
|
1,306 |
1,178 |
$3K |
| 86901 |
|
1,093 |
1,024 |
$3K |
| 86900 |
|
1,096 |
1,025 |
$3K |
| 87186 |
|
2,624 |
2,474 |
$3K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,997 |
1,677 |
$2K |
| 82105 |
|
160 |
153 |
$2K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
457 |
292 |
$2K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
65 |
65 |
$2K |
| 84145 |
|
239 |
187 |
$2K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
84 |
82 |
$2K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
45 |
43 |
$2K |
| 85018 |
|
358 |
353 |
$2K |
| 82947 |
|
209 |
206 |
$2K |
| 85610 |
|
2,253 |
2,061 |
$2K |
| 87507 |
|
18 |
17 |
$2K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
41 |
41 |
$2K |
| 29581 |
|
237 |
94 |
$2K |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
79 |
79 |
$2K |
| 83605 |
|
1,056 |
1,000 |
$2K |
| 77080 |
|
346 |
346 |
$1K |
| 82077 |
|
462 |
427 |
$1K |
| 86140 |
|
1,190 |
926 |
$1K |
| 82607 |
|
958 |
940 |
$1K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
58 |
58 |
$1K |
| 83550 |
|
1,387 |
1,338 |
$1K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,731 |
1,523 |
$1K |
| 84146 |
|
337 |
323 |
$1K |
| 80164 |
|
503 |
455 |
$1K |
| 76830 |
Ultrasound, transvaginal |
12 |
12 |
$1K |
| 85007 |
|
820 |
724 |
$1K |
| 87040 |
|
372 |
352 |
$1K |
| 66984 |
Extracapsular cataract removal with insertion of intraocular lens prosthesis |
25 |
25 |
$1K |
| 83540 |
|
1,540 |
1,487 |
$999.86 |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
12 |
12 |
$993.33 |
| 87077 |
|
1,513 |
1,454 |
$991.98 |
| 80069 |
|
1,674 |
1,456 |
$985.75 |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
91 |
91 |
$911.23 |
| 96367 |
|
154 |
112 |
$902.76 |
| 93971 |
|
55 |
54 |
$869.52 |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
57 |
55 |
$787.76 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
2,681 |
2,346 |
$776.84 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,590 |
1,364 |
$746.07 |
| 76801 |
|
13 |
13 |
$686.76 |
| 86592 |
|
71 |
68 |
$677.05 |
| 93017 |
|
80 |
80 |
$668.31 |
| 82140 |
|
190 |
165 |
$663.58 |
| 83615 |
|
273 |
199 |
$648.05 |
| 82570 |
|
1,861 |
1,778 |
$642.63 |
| 82550 |
|
474 |
403 |
$628.94 |
| 86787 |
|
13 |
13 |
$438.08 |
| 72131 |
|
25 |
25 |
$394.11 |
| 82746 |
|
222 |
218 |
$391.82 |
| J7050 |
Infusion, normal saline solution, 250 cc |
105 |
49 |
$383.13 |
| 85014 |
|
65 |
65 |
$342.89 |
| 85652 |
|
775 |
621 |
$314.25 |
| 82040 |
|
597 |
516 |
$312.97 |
| 87205 |
|
252 |
229 |
$304.87 |
| 85730 |
|
180 |
174 |
$301.28 |
| 84156 |
|
1,017 |
950 |
$278.52 |
| 88342 |
|
74 |
73 |
$278.04 |
| 70486 |
|
13 |
12 |
$270.85 |
| 82150 |
|
220 |
216 |
$236.53 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
573 |
480 |
$231.91 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
28 |
28 |
$230.23 |
| 82565 |
|
583 |
550 |
$227.58 |
| 82805 |
|
27 |
27 |
$215.82 |
| 80299 |
|
27 |
26 |
$172.26 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
439 |
373 |
$171.06 |
| 84550 |
|
687 |
675 |
$168.25 |
| 84153 |
|
303 |
297 |
$166.73 |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
66 |
64 |
$129.78 |
| 80179 |
|
29 |
27 |
$129.34 |
| 80143 |
|
30 |
28 |
$129.34 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
230 |
219 |
$128.78 |
| 82274 |
|
104 |
99 |
$118.24 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
779 |
647 |
$117.40 |
| J2785 |
Injection, regadenoson, 0.1 mg |
38 |
38 |
$111.69 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
1,018 |
933 |
$99.14 |
| 84100 |
|
374 |
349 |
$85.37 |
| J1644 |
Injection, heparin sodium, per 1000 units |
335 |
213 |
$84.91 |
| A6258 |
Transparent film, sterile, more than 16 sq. in. but less than or equal to 48 sq. in., each dressing |
70 |
53 |
$57.98 |
| 84403 |
|
25 |
25 |
$57.04 |
| 82962 |
|
2,809 |
1,953 |
$47.09 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
74 |
64 |
$34.25 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
749 |
698 |
$32.44 |
| 84436 |
|
45 |
44 |
$31.45 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
84 |
78 |
$30.19 |
| C1769 |
Guide wire |
112 |
109 |
$26.38 |
| 80354 |
|
12 |
12 |
$25.62 |
| 83001 |
|
12 |
12 |
$25.45 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
12 |
12 |
$22.56 |
| J1790 |
Injection, droperidol, up to 5 mg |
32 |
30 |
$21.26 |
| J0689 |
Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg |
30 |
27 |
$18.14 |
| 80178 |
|
14 |
13 |
$16.65 |
| 80050 |
General health panel |
13 |
13 |
$12.15 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
15 |
15 |
$11.46 |
| 83883 |
|
26 |
25 |
$11.42 |
| 80197 |
|
21 |
12 |
$10.95 |
| 82248 |
|
111 |
108 |
$7.85 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
13 |
12 |
$7.28 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
13 |
13 |
$3.22 |
| J2060 |
Injection, lorazepam, 2 mg |
14 |
12 |
$1.61 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
270 |
137 |
$0.00 |
| 80177 |
|
13 |
13 |
$0.00 |
| G0378 |
Hospital observation service, per hour |
39 |
37 |
$0.00 |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
13 |
13 |
$0.00 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
14 |
14 |
$0.00 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
3,501 |
3,065 |
$0.00 |
| A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose |
85 |
80 |
$0.00 |
| C1780 |
Lens, intraocular (new technology) |
26 |
26 |
$0.00 |
| 84425 |
|
12 |
12 |
$0.00 |
| 99152 |
|
18 |
18 |
$0.00 |